Literature DB >> 8933785

Endometrial carcinoma: dynamic MRI with turbo-FLASH technique.

I Joja1, M Asakawa, T Asakawa, T Nakagawa, S Kanazawa, M Kuroda, I Togami, Y Hiraki, N Akamatsu, T Kudo.   

Abstract

PURPOSE: Our goal was to investigate the usefulness of dynamic MRI with the turbo-FLASH technique in estimating myometrial invasion by endometrial carcinoma.
METHOD: Forty-six patients with endometrial carcinomas were evaluated with pathologic correlation. Dynamic MRI was performed with the rapid administration of Gd-DTPA using the turbo-FLASH technique.
RESULTS: The inner muscle layer showed more rapid contrast enhancement effects than the outer muscle layer even after menopause. Contrast-to-noise ratio between the inner muscle layer and endometrial carcinoma was maximum at approximately 50 s after administration of Gd-DTPA. In postmenopausal women, the accuracy in estimating myometrial invasion with T2-weighted images, contrast-enhanced T1-weighted images, and dynamic MRI was 66.7, 77.8, and 92.6%, respectively.
CONCLUSION: Dynamic MRI with the turbo-FLASH technique is considered to be a useful imaging method for the estimation of myometrial invasion by endometrial carcinoma, especially in postmenopausal patients.

Entities:  

Mesh:

Year:  1996        PMID: 8933785     DOI: 10.1097/00004728-199611000-00003

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  8 in total

1.  A thickened or indistinct junctional zone on T2-weighted MR images in patients with endometrial carcinoma: pathologic consideration based on microcirculation.

Authors:  Yumiko Oishi Tanaka; Masato Nishida; Hajime Tsunoda; Yoshihito Ichikawa; Yukihisa Saida; Yuji Itai
Journal:  Eur Radiol       Date:  2003-01-25       Impact factor: 5.315

2.  Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T.

Authors:  Gilda Rechichi; Stefania Galimberti; Mauro Signorelli; Patrizia Perego; Maria Grazia Valsecchi; Sandro Sironi
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

3.  Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists.

Authors:  Ingfrid S Haldorsen; Jenny A Husby; Henrica M J Werner; Inger J Magnussen; Jarle Rørvik; Harald Helland; Jone Trovik; Øyvind O Salvesen; Ansgar Espeland; Helga B Salvesen
Journal:  Eur Radiol       Date:  2012-03-28       Impact factor: 5.315

4.  The value of MR imaging when the site of uterine cancer origin is uncertain.

Authors:  Hebert Alberto Vargas; Oguz Akin; Junting Zheng; Chaya Moskowitz; Robert Soslow; Nadeem Abu-Rustum; Richard R Barakat; Hedvig Hricak
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

5.  Pathologies of the uterine endometrial cavity: usual and unusual manifestations and pitfalls on magnetic resonance imaging.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Hisanori Uehara; Shusaku Yoshida; Hiromu Nishitani; Hideki Shimazu
Journal:  Eur Radiol       Date:  2005-06-14       Impact factor: 5.315

6.  Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.

Authors:  Stella Capriglione; Francesco Plotti; Andrea Miranda; Roberto Ricciardi; Giuseppe Scaletta; Alessia Aloisi; Federica Guzzo; Roberto Montera; Roberto Angioli
Journal:  Tumour Biol       Date:  2015-01-11

7.  MR imaging in endometrial carcinoma as a diagnostic tool for the prediction of myometrial invasion and lymph node metastasis.

Authors:  Ui Nam Ryoo; Chel Hun Choi; Ji Yeong Yoon; Soo Kyung Noh; Heeseok Kang; Woo Young Kim; Boh Hyun Kim; Tae-Joong Kim; Jeong-Won Lee; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

8.  Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinoma.

Authors:  Linfeng Zheng; Sujuan Zheng; Xiaochun Yuan; Xifu Wang; Zhuoli Zhang; Guixiang Zhang
Journal:  Onco Targets Ther       Date:  2015-07-17       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.